Loading viewer...
investor_presentation
Format: PDF investor_presentation
Stantec investor presentation from September 2020 outlining the company's strategic initiatives, financial targets, and diversified global footprint. The presentation includes forward-looking statements regarding annual net revenue growth, adjusted EBITDA, and net income targets, alongside discussion of the company's acquisition and capital deployment strategies. With $3.8B in trailing twelve-month revenue as of Q2 2020, Stantec operates across the United States (54%), Canada (29%), and Global markets (17%).
investor_presentation
26 Pages
investor_presentation
32 Pages
Auris Medical Holding